Aysegül Ilhan‐Mutlu

2.4k total citations
71 papers, 1.4k citations indexed

About

Aysegül Ilhan‐Mutlu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Aysegül Ilhan‐Mutlu has authored 71 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 25 papers in Surgery. Recurrent topics in Aysegül Ilhan‐Mutlu's work include Gastric Cancer Management and Outcomes (27 papers), Esophageal Cancer Research and Treatment (23 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Aysegül Ilhan‐Mutlu is often cited by papers focused on Gastric Cancer Management and Outcomes (27 papers), Esophageal Cancer Research and Treatment (23 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Aysegül Ilhan‐Mutlu collaborates with scholars based in Austria, Germany and Switzerland. Aysegül Ilhan‐Mutlu's co-authors include Matthias Preusser, Hannah Christina Puhr, Anna S. Berghoff, Georg Widhalm, Sebastian F. Schoppmann, Peter Birner, Ludwig Wagner, Adelheid Wöhrer, Karin Dieckmann and Christine Marosi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Aysegül Ilhan‐Mutlu

64 papers receiving 1.4k citations

Peers

Countries citing papers authored by Aysegül Ilhan‐Mutlu

Since Specialization

Citations

This map shows the geographic impact of Aysegül Ilhan‐Mutlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aysegül Ilhan‐Mutlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aysegül Ilhan‐Mutlu more than expected).

Fields of papers citing papers by Aysegül Ilhan‐Mutlu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aysegül Ilhan‐Mutlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aysegül Ilhan‐Mutlu. The network helps show where Aysegül Ilhan‐Mutlu may publish in the future.

Co-authorship network of co-authors of Aysegül Ilhan‐Mutlu

This figure shows the co-authorship network connecting the top 25 collaborators of Aysegül Ilhan‐Mutlu. A scholar is included among the top collaborators of Aysegül Ilhan‐Mutlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aysegül Ilhan‐Mutlu. Aysegül Ilhan‐Mutlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lymphovascular Invasion (LVI) Correlates with Systemic Immune-Inflammation Index (SII) in Adenocarcinoma of the Gastroesophageal Junction (AEG): Implications for Prognostic Stratification 2025 ·Cancers ·Gerd Jomrich, (unknown), Dagmar Kollmann, Ivan Kristo, (unknown), Hannah Christina Puhr, Aysegül Ilhan‐Mutlu, (unknown), Reza Asari, Christian Sebesta, Sebastian F. Schoppmann	0
2	Zolbetuximab and the novel biomarker claudin 18.2 in the treatment of gastroesophageal adenocarcinoma 2025 ·memo - Magazine of European Medical Oncology ·Aysegül Ilhan‐Mutlu, Florian Lordick, Ewald Wöll	0
3	Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study 2025 ·European Journal of Cancer ·(unknown), Anne M. May, Antoine Adenis, Andreia Capela, Sarah Derks, (unknown), (unknown), Cinta Hierro, Aysegül Ilhan‐Mutlu, Florian Lordick, Radka Obermannová, Angelica Petrillo, Alberto Puccini, (unknown), Giandomenico Roviello, (unknown), Marije Slingerland, Elizabeth Smyth, Hanneke W.M. van Laarhoven, Nadia Haj Mohammad	1
4	Current Landscape of Molecular Biomarkers in Gastroesophageal Tumors and Potential Strategies for Co-Expression Patterns 2025 ·Cancers ·M. Korpan, Hannah Christina Puhr, J.M. Berger, (unknown), Gerald W. Prager, Matthias Preusser, Aysegül Ilhan‐Mutlu	1
5	Second-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma 2023 ·memo - Magazine of European Medical Oncology ·Aysegül Ilhan‐Mutlu, Ewald Wöll	0
6	Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score) 2022 ·ESMO Open ·Hannah Christina Puhr, (unknown), (unknown), (unknown), (unknown), (unknown), Matthias Paireder, Gerd Jomrich, Sebastian F. Schoppmann, Anna S. Berghoff, Matthias Preusser, Aysegül Ilhan‐Mutlu	0
7	Absorption of Direct Oral Anticoagulants in Cancer Patients after Gastrectomy 2022 ·Pharmaceutics ·Hannah Christina Puhr, Aysegül Ilhan‐Mutlu, Matthias Preusser, Peter Quehenberger, Paul A. Kyrle, Sabine Eichinger, Lisbeth Eischer	5
8	Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome 2020 ·ESMO Open ·Hannah Christina Puhr, Eleonore Pablik, Anna S. Berghoff, Gerd Jomrich, Sebastian F. Schoppmann, Matthias Preusser, Aysegül Ilhan‐Mutlu	7
9	Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours 2020 ·ESMO Open ·Maximilian J. Mair, (unknown), Aysegül Ilhan‐Mutlu, Ariane Steindl, Barbara Kiesel, Georg Widhalm, Karin Dieckmann, (unknown), Johannes A. Hainfellner, Christine Marosi, Leonhard Müllauer, Ludwig Wagner, Matthias Preusser, Anna S. Berghoff	16
10	Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma 2016 ·Molecular Cancer Therapeutics ·Aysegül Ilhan‐Mutlu, Matthias Osswald, Yunxiang Liao, Miriam Gömmel, Martin Reck, David Miles, Paola Mariani, Luca Gianni, Beatrix Lutiger, (unknown), Stefanie Srock, Pablo Ernesto Pérez, Frits Thorsen, Louisa von Baumgarten, Matthias Preusser, Wolfgang Wick, Frank Winkler	86
11	microRNA-21 Expression is Elevated in Esophageal Adenocarcinoma After Neoadjuvant Chemotherapy 2015 ·Cancer Investigation ·Aysegül Ilhan‐Mutlu, Gülçin Tezcan, Sebastian F. Schoppmann, Matthias Preusser, (unknown), Georgios Karanikas, Peter Birner	8
12	NephroCheck data compared to serum creatinine in various clinical settings 2015 ·BMC Nephrology ·(unknown), Aysegül Ilhan‐Mutlu, Matthias Preusser, R. Roka, Wilfred Druml, Ludwig Wagner	33
13	Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapies. 2013 ·PubMed ·Matthias Preusser, Anna S. Berghoff, Aysegül Ilhan‐Mutlu, Carina Dinhof, Manuel Magerle, Christine Marosi, Michael Hejna, David Capper, Andreas von Deimling, Sebastian F. Schoppmann, Peter Birner	18
14	ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer 2013 ·Lung Cancer ·Matthias Preusser, Anna S. Berghoff, Aysegül Ilhan‐Mutlu, Manuel Magerle, Carina Dinhof, Georg Widhalm, Karin Dieckmann, Christine Marosi, Adelheid Wöhrer, Monika Hackl, Sabine Zöchbauer‐Müller, Andreas von Deimling, Sebastian F. Schoppmann, Christoph Zielinski, Berthold Streubel, Peter Birner	58
15	Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens 2013 ·Journal of Neuro-Oncology ·Aysegül Ilhan‐Mutlu, Adelheid Wöhrer, Anna S. Berghoff, Georg Widhalm, Christine Marosi, Ludwig Wagner, Matthias Preusser	11
16	High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer 2013 ·Lung Cancer ·Matthias Preusser, Anna S. Berghoff, Walter Berger, Aysegül Ilhan‐Mutlu, Carina Dinhof, Georg Widhalm, Karin Dieckmann, Adelheid Wöhrer, Monika Hackl, Andreas von Deimling, Berthold Streubel, Peter Birner	59
17	Brain metastases: pathobiology and emerging targeted therapies 2012 ·Acta Neuropathologica ·Matthias Preusser, David Capper, Aysegül Ilhan‐Mutlu, Anna S. Berghoff, Peter Birner, Rupert Bartsch, Christine Marosi, Christoph Zielinski, Minesh P. Mehta, Frank Winkler, Wolfgang Wick, Andreas von Deimling	145
18	Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors 2012 ·British Journal of Cancer ·Anna S. Berghoff, Zsuzsanna Bagó-Horváth, Aysegül Ilhan‐Mutlu, Manuel Magerle, Karin Dieckmann, Christine Marosi, P. Birner, Georg Widhalm, Guenther G. Steger, Christoph Zielinski, Rupert Bartsch, Matthias Preusser	23
19	Exploratory investigation of eight circulating plasma markers in brain tumor patients 2012 ·Neurosurgical Review ·Aysegül Ilhan‐Mutlu, Ludwig Wagner, Georg Widhalm, Adelheid Wöhrer, Sophie Bartsch, Thomas Czech, Harald Heinzl, Fritz Leutmezer, Daniela Prayer, Christine Marosi, Wolfgang Base, Matthias Preusser	47
20	Blood Alterations Preceding Clinical Manifestation of Glioblastoma 2012 ·Cancer Investigation ·Aysegül Ilhan‐Mutlu, Ludwig Wagner, Adelheid Wöhrer, Susanne Jungwirth, Christine Marosi, Peter Fischer, Matthias Preusser	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact